Home   >  
Protease/Metabolic Enzyme
  • Protease/Metabolic Enzyme

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products






Raw Materials


Chemical Structure Cat. No. Product Name CAS No.
Melagatran Chemical Structure
BCP16010 Melagatran 159776-70-2
Melagatran is a synthetic thrombin inhibitor. Thrombin mutant anticoagulant antagonist. Antithrombotic.
Vorapaxar Chemical Structure
BCP08286 Vorapaxar 618385-01-6
Vorapaxar, also known as SCH 530348, is a thrombin receptor (protease-activated receptor, PAR-1) antagonist based on the natural product himbacine.
21R-Argatroban Chemical Structure
BCP12713 21R-Argatroban 121785-71-5
Argatroban is a direct, selective thrombin inhibitor.
D-PHE-PIP-ARG-PNA Chemical Structure
BCP18445 D-PHE-PIP-ARG-PNA 115388-96-0
Thrombin substrates are often cleaved as well by trypsin and trypsin-like enzymes, e.g. I-1365, I-1560, J-1120, and L-1150. Chromogenic substrate specific for thrombin but insensitive to factor Xa.
Argatroban Chemical Structure
BCP06831 Argatroban 74863-84-6
Argatroban is a direct, selective thrombin inhibitor.
Argatroban monohydrate Chemical Structure
BCP09304 Argatroban monohydrate 141396-28-3
Argatroban monohydrate is a direct, selective thrombin inhibitor.Argatroban is a potent, seletive, univalent direct inhibitor of thrombin.
Metolazone Chemical Structure
BCP21574 Metolazone 17560-51-9
Metolazone is primarily used to treat congestive heart failure and high blood pressure.
Bivalirudin Trifluoroacetate Chemical Structure
BCP02040 Bivalirudin Trifluoroacetate 128270-60-0
Bivalirudin is a synthetic 20 residue peptide (thrombin inhibitor) which reversibly inhibits thrombin.
Dabigatran ethyl ester Chemical Structure
BCP12049 Dabigatran ethyl ester 429658-95-7
Ethyl ester of Dabigatran, which is an emerging oral anticoagulant which is a direct inhibitor of thrombin activity.
Dabigatran etexilate mesylate Chemical Structure
BCP06644 Dabigatran etexilate mesylate 872728-81-9
Dabigatran is a reversible and selective, direct thrombin inhibitor (DTI) undergoing advanced clinical development as its orally active prodrug,dabigatran etexilate.
12下一页共 12 条记录 1 / 2 页